EXHIBIT 99.2

HEADLINE: Total Renal Care Holdings, Inc. Announces Intention to Place
Convertible Subordinated Notes

DATELINE: Torrance, CA November 9

BODY:
          Total Renal Care Holdings, Inc. (NYSE: TRL) today announced that it
has commenced marketing an offering of up to $300,000,000 (plus a 15% over-
allotment option) of Convertible Subordinated Notes (the "Notes"). The Notes
will be sold only to qualified institutional buyers pursuant to Rule 144A. The
Company intends to use the net proceeds from any sale of the Notes to pay down
revolving debt.

          The Notes have not been registered under the Securities Act of 1933 or
state securities laws and may not be offered or sold in the United States absent
registration or qualification or an applicable exemption from registration or
qualification requirements.

          Torrance-based Total Renal Care Holdings, Inc. is the second largest
domestic and largest independent worldwide provider of integrated dialysis
services for patients suffering from chronic kidney failure. The Company owns
and operates high-quality, free-standing kidney dialysis centers and home
peritoneal dialysis programs in 33 states, as well as Washington, D.C., Puerto
Rico, Guam, Argentina, and Europe, and also provides high-quality acute
hemodialysis services to inpatients at approximately 306 hospitals. Currently,
TRL will operate 492 outpatient dialysis facilities and provide services to
approximately 37,900 patients, with approximately 2,200 patients in 35 centers
under TRL management (including patients to be served under the Satellite
Dialysis Centers agreement, which is effective December 1, 1998). The company
additionally operates ESRD laboratory and pharmacy facilities, as well as
vascular access management, transplant services and ESRD clinical research
programs.